In the Philippines, has created a vaccine for COVID-19, which you can drink beer

Most vaccines in use today, with the exception of certain drugs against polio, are introduced into the body through injection. Working in this direction and the creators of the funds from the coronavirus. However, not all – Filipino scientist Nicanor of Austriaco (Nicanor Austriaco) went their own way – he completes work on a vaccine that can be dissolved in any liquid, including beer and just drink.

Creator of the unique drug Nicanor of Austriaco not only a scientist, but a priest. In childhood, he decided that he would dedicate his life to the people and while no one could accuse him of hypocrisy. Last year Nicanor spent on the creation of a vaccine against COVID-19 that could save millions of lives.

The basis of preparation of the Philippine scientist are the yeast of the species Saccharomyces boulardii, the study of which Nicanor devoted 25 years of his life. It is the yeast was the subject of his thesis work at mit and they sure Austriaco, save humanity from the threat of the virus.

Yeast underlying vaccines have long been used as a probiotic, but the Philippine genius Microbiology modified them at the genetic level. Now the yeast and produce spickovy a protein that promotes development of immunity to the coronavirus.

Important features of the development was not only a property of the yeast vaccine to dissolve in the beer, water, milk or any liquid without loss of properties. Vaccine Dr. Austriaco be stored in special refrigerators, and so can easily be transported to any distance in the country and beyond.

For the Philippines, where many people in remote areas have not only to refrigerators, but also access to electricity is particularly important. Now the vaccine can be delivered in capsules in any place, to dissolve any beverage to drink. It does not even need medical staff!

Now the vaccine is tested on rodents at the University of Santo tomás in Manila, and by the end of the year Nicanor of Austriaco hopes to begin clinical trials. It is possible that in early 2022, an unusual means to protect against COVID-19 will begin to be mass-produced.